These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10826112)

  • 41. Cefditoren, a new aminothiazolyl cephalosporin.
    Balbisi EA
    Pharmacotherapy; 2002 Oct; 22(10):1278-93. PubMed ID: 12389878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A clinical study on cefditoren pivoxil granules in the pediatric field].
    Mori A; Meguro H; Terashima I; Fujii R
    Jpn J Antibiot; 1993 Jul; 46(7):577-88. PubMed ID: 8371493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients].
    Fujii R; Chiba S; Numazaki K; Mori T; Terashima I; Meguro H; Mori A; Toyonaga Y; Sunakawa K; Satoh Y
    Jpn J Antibiot; 1993 Oct; 46(10):926-37. PubMed ID: 8254895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation and characterization of high-surface-area polymer substrates for microcalorimetry.
    Lee VA; Craig RG; Filisko FE; Zand R
    J Biomed Mater Res; 1996 May; 31(1):51-62. PubMed ID: 8731149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A clinical study on cefditoren pivoxil in pediatrics].
    Satoh Y; Iwata S; Akita H; Aoyama T; Takeuchi Y; Yokota T; Sunakawa K
    Jpn J Antibiot; 1993 Jul; 46(7):596-603. PubMed ID: 8371495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary.
    Nagy E; Marton A; Hajdú E
    Acta Microbiol Immunol Hung; 2003; 50(2-3):119-24. PubMed ID: 12894483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adsorption of trichloroethene at the vapor/water interface.
    Bruant RG; Conklin MH
    Environ Sci Technol; 2001 Jan; 35(2):362-4. PubMed ID: 11347610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A multicenter study of 7-day cefditoren pivoxil treatment for group A streptococcal infection].
    Sakata H
    Jpn J Antibiot; 2007 Oct; 60(5):257-63. PubMed ID: 18198654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Water adsorption on the stoichiometric (001) and (010) surfaces of hydroxyapatite: a periodic B3LYP study.
    Corno M; Busco C; Bolis V; Tosoni S; Ugliengo P
    Langmuir; 2009 Feb; 25(4):2188-98. PubMed ID: 19161264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Applicability of the one-step DVS method for the determination of amorphous amounts for further different hydrophilic and hydrophobic drugs.
    Müller T; Scherließ R; Schiewe J; Smal R; Weiler C; Steckel H
    Eur J Pharm Biopharm; 2015 Aug; 94():333-41. PubMed ID: 26079523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.
    Miller DP; Lechuga-Ballesteros D
    Pharm Res; 2006 Oct; 23(10):2291-305. PubMed ID: 16955371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antibiotic therapy against acute tonsillopharyngitis in children due to group A beta-hemolytic streptococci: comparison of clinical efficacy, the bactericidal effects, and effects on oral flora between cefditoren pivoxil for 5 days and amoxicillin for 10 days].
    Tsumura N; Nagai K; Hidaka H; Otsu Y; Tanaka Y; Ikezawa S; Honma S; Shindo S; Ubukata K
    Jpn J Antibiot; 2011 Jun; 64(3):179-90. PubMed ID: 21861309
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population pharmacokinetic analysis of cefditoren pivoxil in pediatric patients with infection.
    Matsumoto K; Sato N; Mitomi N; Shibasaki S
    Jpn J Antibiot; 2013 Dec; 66(6):357-75. PubMed ID: 24649799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical studies of cefditoren pivoxil in pediatric field].
    Nishimura T; Tabuki K; Aoki S; Takagi M
    Jpn J Antibiot; 1993 Jul; 46(7):629-36. PubMed ID: 8371497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population pharmacokinetics of cefditoren pivoxil in non-infected adults.
    Matsumoto K; Sato N; Mitomi N; Shitara Y; Shibasaki S
    Jpn J Antibiot; 2014 Feb; 67(1):49-66. PubMed ID: 24809208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of amorphous content by microcalorimetry.
    Kawakami K; Numa T; Ida Y
    J Pharm Sci; 2002 Feb; 91(2):417-23. PubMed ID: 11835201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Water vapor adsorption behavior of sodium deoxycholate anhydrous forms.
    Ono M; Anzai H; Tozuka Y; Moribe K; Oguchi T; Yamamoto K
    Chem Pharm Bull (Tokyo); 2005 Feb; 53(2):180-3. PubMed ID: 15684517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of amorphous ursodeoxycholic acid by thermal methods.
    Yonemochi E; Ueno Y; Ohmae T; Oguchi T; Nakajima S; Yamamoto K
    Pharm Res; 1997 Jun; 14(6):798-803. PubMed ID: 9210200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of silver nanoparticles to the chemiluminescence determination of cefditoren pivoxil using the luminol-ferricyanide system.
    Alarfaj NA; Aly FA; El-Tohamy MF
    Luminescence; 2015 Feb; 30(1):91-7. PubMed ID: 24850667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydration of microcrystalline cellulose and milled cellulose studied by sorption calorimetry.
    Kocherbitov V; Ulvenlund S; Kober M; Jarring K; Arnebrant T
    J Phys Chem B; 2008 Mar; 112(12):3728-34. PubMed ID: 18307340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.